Skip to main content

Articles

Page 101 of 335

  1. Alternatively-activated macrophages (AAMs), an anti-inflammatory macrophage subpopulation, have been implicated in the progression of high grade serous ovarian carcinoma (HGSOC). Increased levels of AAMs are c...

    Authors: Kaitlin C. Fogg, Andrew E. Miller, Ying Li, Will Flanigan, Alyssa Walker, Andrea O’Shea, Christina Kendziorski and Pamela K. Kreeger
    Citation: BMC Cancer 2020 20:1008
  2. The positive response and the clinical usefulness of 14 serum antibodies in patients with esophageal squamous cell carcinoma (ESCC) were examined in this study. The Cancer Genome Atlas (TCGA) was used to inves...

    Authors: Isamu Hoshino, Yoshihiro Nabeya, Nobuhiro Takiguchi, Hisashi Gunji, Fumitaka Ishige, Yosuke Iwatate, Akiko Kuwajima, Fumiaki Shiratori, Rei Okada and Hideaki Shimada
    Citation: BMC Cancer 2020 20:1007
  3. The aim of this study was to explore the utility of circulating free DNA (cfDNA) in the evaluation of clinical tumor burden and survival in Chinese patients with metastatic colorectal cancer (mCRC) and to prel...

    Authors: Xiaojing Xu, Yiyi Yu, Minna Shen, Mengling Liu, Shengchao Wu, Li Liang, Fei Huang, Chenlu Zhang, Wei Guo and Tianshu Liu
    Citation: BMC Cancer 2020 20:1006
  4. An increasing number of studies have reported circular RNAs (circRNAs) as new potential biomarkers for the prognosis of gliomas. However, the overall prognostic value of circRNAs for glioma remains unclear. Th...

    Authors: Xiangqian Ding, Luyao Yang, Xin Geng, Yanghong Zou, Zhigang Wang, Yao Li, Renli Qi, Wei Wang, Jinghui Li and Hualin Yu
    Citation: BMC Cancer 2020 20:1005
  5. Baseline cardiovascular disease (CVD) can impact the patterns of treatment and hence the outcomes of patients with lung cancer. This study aimed to characterize treatment trends and survival outcomes of patien...

    Authors: Atul Batra, Dropen Sheka, Shiying Kong and Winson Y. Cheung
    Citation: BMC Cancer 2020 20:1004
  6. Increasing studies indicated that microRNA-203 (miR-203) may play an important part in the prognosis of CRC. Nevertheless, the prognostic and influential mechanism of miR-203 expression in CRC remains to be in...

    Authors: Qiliang Peng, Yi Shen, Peifeng Zhao, Shang Cai, Zhengyang Feng, Ming Cheng, Yongyou Wu and Yaqun Zhu
    Citation: BMC Cancer 2020 20:1003
  7. The relationship between sarcopenia and the prognoses of patients with gastric neuroendocrine neoplasms (g-NENs) is unclear. This study was designed to explore the effects of sarcopenia on short-term and long-...

    Authors: Jia-bin Wang, Zhen Xue, Jun Lu, Qing-liang He, Zhi-fang Zheng, Bin-bin Xu, Jian-wei Xie, Ping Li, Yu Xu, Jian-xian Lin, Qi-yue Chen, Long-long Cao, Mi Lin, Ru-hong Tu, Ze-ning Huang, Ju-li Lin…
    Citation: BMC Cancer 2020 20:1002
  8. Histone deacetylase inhibitors (HDACIs) have distinctive epigenetic targets involved in hepatocarcinogenesis and chemoresistance. A recent phase I/II study reported the possibility of HDACI as a chemosensitize...

    Authors: Young Chang, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim and Jung-Hwan Yoon
    Citation: BMC Cancer 2020 20:1001
  9. MCM5 is a protein involved in DNA replication, facilitating cell proliferation. In normal epithelium MCM5 expression is restricted to the cells in the basal proliferative compartments, however in the presence ...

    Authors: J. Stockley, R. Akhand, A. Kennedy, C. Nyberg, E. J. Crosbie and R. J. Edmondson
    Citation: BMC Cancer 2020 20:1000
  10. Cervical cancer is the second-most common gynecological cancer, early screening plays a key role in the diagnosis and treatment of cervical intraepithelial neoplasia (CIN). Sustained E7 protein expression is t...

    Authors: Linghua Kong, Xiaoping Xiao, Huiping Lou, Pengfei Liu, Shuhui Song, Moudu Liu, Tao Xu, Ying Zhang, Caijuan Li, Ruoli Guan, Yan Li, Xin Yu, Haiyuan Liu, Qingbo Fan, Honghui Shi and Lan Zhu
    Citation: BMC Cancer 2020 20:999

    The Correction to this article has been published in BMC Cancer 2020 20:1027

  11. Triple-negative breast cancer (TNBC), in part because of the high metastasis rate, is one of the most prevalent causes of malignancy-related mortality globally. Ubiquitin specific peptidase 6 N-terminal like (...

    Authors: Teng Ma, Huaidong Liu, Yan Liu, Tingting Liu, Hui Wang, Fulu Qiao, Lu Song and Lin Zhang
    Citation: BMC Cancer 2020 20:998
  12. Successful local therapy for oligometastases may lead to longer survival. The purpose of this multicentre retrospective study was to investigate factors affecting the local control (LC) of pulmonary oligometas...

    Authors: Takaya Yamamoto, Yuzuru Niibe, Masahiko Aoki, Takashi Shintani, Kazunari Yamada, Mitsuru Kobayashi, Hideomi Yamashita, Masatoki Ozaki, Yoshihiko Manabe, Hiroshi Onishi, Katsuya Yahara, Atsushi Nishikawa, Kuniaki Katsui, Ryoong-Jin Oh, Atsuro Terahara and Keiichi Jingu
    Citation: BMC Cancer 2020 20:997
  13. Angiogenesis is important for the progression of gastric cancer (GC). Y-box binding protein 1 (YB-1) predicts advanced disease and indicates neovasculature formation in GC tissues, while the related mechanisms...

    Authors: Xiaoxia Xue, Jin Huang, Kai Yu, Xinyue Chen, Yini He, Dianjun Qi and Ying Wu
    Citation: BMC Cancer 2020 20:996
  14. Historically, amputation was the primary surgical treatment for osteosarcoma of the extremities; however, with advancements in surgical techniques and chemotherapies limb salvage has replaced amputation as the...

    Authors: Daniel R. Evans, Alexander L. Lazarides, Julia D. Visgauss, Jason A. Somarelli, Dan G. Blazer III, Brian E. Brigman and William C. Eward
    Citation: BMC Cancer 2020 20:995
  15. The BRCA mutation (BRCAm) in males has been reported to confer a higher risk for the development of various tumors. However, little is known about its clinicopathologic features and prognostic implications.

    Authors: Peng Sun, Yue Li, Xue Chao, Jibin Li, Rongzhen Luo, Mei Li and Jiehua He
    Citation: BMC Cancer 2020 20:994
  16. Increasing evidence indicates that the pathology and the modified Kadish system have some influence on the prognosis of esthesioneuroblastoma (ENB). However, an accurate system to combine pathology with a modi...

    Authors: Lijie Jiang, Tengjiao Lin, Yu Zhang, Wenxiang Gao, Jie Deng, Zhaofeng Xu, Xin Luo, Zhaoqi Huang, Fenghong Chen, Jianbo Shi and Yinyan Lai
    Citation: BMC Cancer 2020 20:993
  17. Treatment with ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) is a well-established therapy for advanced Hodgkin’s lymphoma (HL). However, the recently completed ECHELON-1 trial showed potential n...

    Authors: A. J. N. Raymakers, S. Costa, D. Cameron and D. A. Regier
    Citation: BMC Cancer 2020 20:992
  18. The aim of this study was to determine the safety and efficacy of fractionated stereotactic radiotherapy (SRT) in combination with systemic therapies (ST) for brain metastases (BM).

    Authors: Morgan Guénolé, François Lucia, Vincent Bourbonne, Gurvan Dissaux, Emmanuelle Reygagne, Gaëlle Goasduff, Olivier Pradier and Ulrike Schick
    Citation: BMC Cancer 2020 20:991
  19. In this study, we analyze the cost-effectiveness of fruquintinib as third-line treatment for patients with metastatic colorectal cancer in China, especially after a recent price drop suggested by the National ...

    Authors: Zhi Peng, Xingduo Hou, Yangmu Huang, Tong Xie and Xinyang Hua
    Citation: BMC Cancer 2020 20:990
  20. Increasing studies have demonstrated that activated platelets play an essential role in tumour progression. However, the level and prognostic role of platelet indices in chordoma patients remain unclear. The a...

    Authors: Mingxuan Li, Jiwei Bai, Shuai Wang, Yixuan Zhai, Shuheng Zhang, Chuzhong Li, Jiang Du and Yazhuo Zhang
    Citation: BMC Cancer 2020 20:988
  21. In bone-invasive oral squamous cell carcinoma (OSCC), cancer-associated fibroblasts (CAFs) infiltrate into bony tissue ahead of OSCC cells. In the present study, we aimed to investigate the role of the Axin2-S...

    Authors: Yin-Zhe An, Eunae Cho, Junqi Ling and Xianglan Zhang
    Citation: BMC Cancer 2020 20:987
  22. Idiopathic pulmonary fibrosis (IPF) is associated with an increased risk for lung cancer, but the underlying mechanisms driving malignant transformation remain largely unknown. This study aimed to identify dif...

    Authors: Dong Leng, Jiawen Yi, Maodong Xiang, Hongying Zhao and Yuhui Zhang
    Citation: BMC Cancer 2020 20:986
  23. Esophageal cancer (EC) is considered as one of the deadliest malignancies with respect to incidence and mortality rate, and numerous risk factors may affect the prognosis of EC patients. For better understandi...

    Authors: Jingcheng Yang, Jun Shang, Qian Song, Zuyi Yang, Jianing Chen, Ying Yu and Leming Shi
    Citation: BMC Cancer 2020 20:985
  24. Cytarabine (ara-C) is the major drug for the treatment of acute myeloid leukemia (AML), but cellular resistance to ara-C is a major obstacle to therapeutic success. The present study examined enhanced anti-apo...

    Authors: Rie Nishi, Hiroko Shigemi, Eiju Negoro, Miyuki Okura, Naoko Hosono and Takahiro Yamauchi
    Citation: BMC Cancer 2020 20:984
  25. Moroccan incidence of cancer is increasing with the lengthening of life expectancy. Data regarding elderly Moroccan cancer patients are lacking. In the context of our project aiming to develop an adapted versi...

    Authors: Mounia Amzerin, Mohamed Layachi, Aziz Bazine, Rachid Aassab, Samia Arifi, Zineb Benbrahim, Mohamed Reda Khmamouche, Mouna Kairouani, Hanan Raiss, Noura Majid, Saloua Ouaouch, Mohammed Ichou, Said Afqir, Nawfal Mellas, Mohamed Fetohi, Rachid Razine…
    Citation: BMC Cancer 2020 20:983
  26. 5–10% of patients are diagnosed with metastatic breast cancer (MBC) at the initial diagnosis. This study aimed to develop a nomogram to predict the overall survival (OS) of these patients.

    Authors: Wen Zhao, Lei Wu, Andi Zhao, Mi Zhang, Qi Tian, Yanwei Shen, Fan Wang, Biyuan Wang, Le Wang, Ling Chen, Xiaoai Zhao, Danfeng Dong, Lingxiao Zhang and Jin Yang
    Citation: BMC Cancer 2020 20:982
  27. Growing evidence indicates that the systemic inflammatory response plays an important role in cancer development and progression. Several inflammatory markers have been reported to be associated with clinical ...

    Authors: Shuxin Sun, Chaobin He, Jun Wang, Xin Huang, Jiali Wu and Shengping Li
    Citation: BMC Cancer 2020 20:981
  28. Serum lipids were reported to be the prognostic factors of various cancers, but their prognostic value in malignant biliary tumor (MBT) patients remains unclear. Thus we aim to assess and compare prognosis val...

    Authors: Lejia Sun, Xin Ji, Dongyue Wang, Ai Guan, Yao Xiao, Haifeng Xu, Shunda Du, Yiyao Xu, Haitao Zhao, Xin Lu, Xinting Sang, Shouxian Zhong, Huayu Yang and Yilei Mao
    Citation: BMC Cancer 2020 20:980
  29. Central nervous system germ cell tumors (CNS GCTs) are a heterogeneous group of brain tumors, which are more common in Asian countries. There have been different therapeutic strategies in treating germinoma an...

    Authors: Kyung Taek Hong, Da Hye Lee, Bo Kyung Kim, Hong Yul An, Jung Yoon Choi, Ji Hoon Phi, Jung-Eun Cheon, Hyoung Jin Kang, Seung-Ki Kim, Joo-Young Kim, Sung-Hye Park, Il Han Kim and Hee Young Shin
    Citation: BMC Cancer 2020 20:979
  30. Patients with high-risk prostate cancer are at increased risk of lymph node metastasis and are thought to benefit from whole pelvis radiotherapy (WPRT). There has been recent interest in the use of hypofractio...

    Authors: Lucas C. Mendez, Andrew J. Arifin, Glenn S. Bauman, Vikram M. Velker, Belal Ahmad, Michael Lock, Varagur M. Venkatesan, Tracy L. Sexton, George B. Rodrigues, Jeff Chen, Bryan Schaly, Andrew Warner and David P. D’Souza
    Citation: BMC Cancer 2020 20:978
  31. Primary hepatic sarcomatous carcinoma (PHSC) and primary hepatic sarcoma (PHS) are rare malignancies with frequent overlap in both the clinic and radiology. No comparative study of these tumors for the restric...

    Authors: Dongli Shi, Jun Sun, Liang Ma, Jing Chang and Hongjun Li
    Citation: BMC Cancer 2020 20:977
  32. lncRNA MIR17HG was upregulated in glioma, and participated in promoting proliferation, migration and invasion of glioma. However, the role of MIR17HG polymorphisms in the occurrence and prognosis of glioma is sti...

    Authors: Jigao Feng, Yibin Ouyang, Dedong Xu, Qinglong He, Dayuan Liu, Xudong Fan, Pengxiang Xu and Yehe Mo
    Citation: BMC Cancer 2020 20:976
  33. Currently, oral targeted therapies are known to be effective and are frequently used to treat metastatic cancer patients, but fatigue is a frequently reported early side effect of these treatments. This fatigu...

    Authors: Florence Joly, Claudia Lefeuvre-Plesse, Claire Garnier-Tixidre, Carole Helissey, Nathalie Menneveau, Alain Zannetti, Sebastien Salas, Nadine Houede, Sophie Abadie-Lacourtoisie, Laetitia Stefani, Soazig Nenan, Isabelle Rieger, Isabelle Durand-Zaleski, Jean-Marc Descotes and Amélie Anota
    Citation: BMC Cancer 2020 20:975
  34. Brain metastasis represents a major complication with a significantly shorter overall survival of many oncological diseases, in particular of lung cancer, breast cancer and malignant melanoma patients. However...

    Authors: Annalen Bleckmann, Benjamin Kirchner, Manuel Nietert, Micha Peeck, Marko Balkenhol, Daniela Egert, T. Veit Rohde, Tim Beißbarth and Tobias Pukrop
    Citation: BMC Cancer 2020 20:973
  35. The aim was to estimate the risk of subsequent extra-cervical Human Papillomavirus (HPV) related cancer in patients surgically treated for high grade cervical intraepithelial neoplasia (CIN 2–3). This is the f...

    Authors: Mario Preti, Stefano Rosso, Leonardo Micheletti, Carola Libero, Irene Sobrato, Livia Giordano, Paola Busso, Niccolò Gallio, Stefano Cosma, Federica Bevilacqua and Chiara Benedetto
    Citation: BMC Cancer 2020 20:972
  36. Optimal management strategies for clinically localised prostate cancer are debated. Using median 10-year data from the largest randomised controlled trial to date (ProtecT), the lifetime cost-effectiveness of ...

    Authors: S. Sanghera, S. Mohiuddin, J. Coast, K. Garfield, S. Noble, C. Metcalfe, J. A. Lane, E. L. Turner, D. Neal, F. C. Hamdy, R. M. Martin and J. L. Donovan
    Citation: BMC Cancer 2020 20:971
  37. New treatment options for ovarian cancer are urgently required. Tumor-associated macrophages (TAMs) are an attractive target for therapy; repolarizing TAMs from M2 (pro-tumor) to M1 (anti-tumor) phenotypes rep...

    Authors: Alyssa A. Hoover, Demetra H. Hufnagel, Whitney Harris, Kennady Bullock, Evan B. Glass, Esther Liu, Whitney Barham, Marta A. Crispens, Dineo Khabele, Todd D. Giorgio, Andrew J. Wilson and Fiona E. Yull
    Citation: BMC Cancer 2020 20:970
  38. Hepatocellular carcinoma (HCC) is the leading cause of primary liver cancers. Surveillance of individuals at specific risk of developing HCC, early diagnostic markers, and new therapeutic approaches are essent...

    Authors: Veronica Bazzani, Arianna Barchiesi, Dorota Radecka, Riccardo Pravisani, Antonio Guadagno, Carla Di Loreto, Umberto Baccarani and Carlo Vascotto
    Citation: BMC Cancer 2020 20:969
  39. Malignant tumours of the temporomandibular joint (MTTMJ) are extremely rare. Studies describing its unique epidemiology, clinicopathological features, treatment and prognosis comprehensively are limited. To ad...

    Authors: Feiluore Yibulayin, Chen-xi Yu, Lei Feng, Meng Wang, Meng-meng Lu, Yuan Luo, Hui Liu, Zhi-cheng Yang and Alimujiang Wushou
    Citation: BMC Cancer 2020 20:967
  40. Nuclear factor of activated T cells 2 (NFAT2) has been reported to regulate the development and malignancy of few tumors. In this study, we aimed to explore the effect of NFAT2 expression on cell fate of HepG2...

    Authors: Jian Wang, Yamin Zhang, Lei Liu, Zilin Cui, Rui Shi, Jiancun Hou, Zirong Liu, Long Yang, Lianjiang Wang and Yang Li
    Citation: BMC Cancer 2020 20:966
  41. Risk-based breast cancer screening may improve the benefit-harm ratio of screening by tailoring policy to a woman’s personal breast cancer risk. This study aims to explore Dutch women’s preferences regarding t...

    Authors: Linda Rainey, Daniëlle van der Waal and Mireille J. M. Broeders
    Citation: BMC Cancer 2020 20:965
  42. Previous studies have shown a major green tea polyphenol (−)-epigallocatechin-3-gallate ((−)-EGCG) as a powerful anti-cancer agent. However, its poor bioavailability and requirement of a high dosage to manifes...

    Authors: Gene Chi Wai Man, Jianzhang Wang, Yi Song, Jack Ho Wong, Yu Zhao, Tat San Lau, Kam Tong Leung, Tak Hang Chan, Huating Wang, Joseph Kwong, Tzi Bun Ng and Chi Chiu Wang
    Citation: BMC Cancer 2020 20:964
  43. Healthy Living after Cancer (HLaC) was a national dissemination and implementation study of an evidence-based lifestyle intervention for cancer survivors. The program was imbedded into existing telephone cance...

    Authors: Elizabeth G. Eakin, Marina M. Reeves, Ana D. Goode, Elisabeth A. H. Winkler, Janette L. Vardy, Frances Boyle, Marion R. Haas, Janet E. Hiller, Gita D. Mishra, Michael Jefford, Bogda Koczwara, Christobel M. Saunders, Kathy Chapman, Liz Hing, Anna G. Boltong, Katherine Lane…
    Citation: BMC Cancer 2020 20:963
  44. The literature suggests an increased risk between anthropometrics including higher body mass index and lymphoma incidence; however, the association with physical activity remains unclear. A systematic review/m...

    Authors: Gwynivere A. Davies, Christopher Strader, Richa Chibbar, Stefania Papatheodorou and Adam A. Dmytriw
    Citation: BMC Cancer 2020 20:962
  45. Durvalumab is a standard drug used during maintenance therapy after chemoradiotherapy in patients with locally advanced non-small cell lung cancer (LA-NSCLC). However, little is known about the clinical benefi...

    Authors: Kyoichi Kaira, Atsuto Mouri, Shingo Kato, Kenichi Yoshimura, Hiroshi Kagamu and Kunihiko Kobayashi
    Citation: BMC Cancer 2020 20:961
  46. The metzincin family of metalloproteinases and the tissue inhibitors of metalloproteinases (TIMPs) are essential proteins required for biological processes during cancer progression. This study aimed to determ...

    Authors: Ruth M. Escalona, Maree Bilandzic, Patrick Western, Elif Kadife, George Kannourakis, Jock K. Findlay and Nuzhat Ahmed
    Citation: BMC Cancer 2020 20:960

Featured videos

View featured videos from across the BMC-series journals